Joanne Holland
Vermogen: 84 000 $ op 31-08-2026
Vermogen: 84 000 $ op 31-08-2026
Joanne Holland was the founder of Nuformix Plc, founded in 2008, serving as Executive Director in 2021.
Dr. Holland is currently the Chief Scientific Officer at CDT Equity, Inc., starting in 2024.
Formerly, Director, Chief Scientific & Technology Officer at Nuformix Technologies Ltd. from 2008 to 2021.
Education includes a doctorate from the University of Leeds.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
NUFORMIX PLC 1,44% | 28-01-2025 | 37.500.000 ( 1,44% ) | 84 000 $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| CDT EQUITY INC. | Hoofd Techniek/Wetenschap/O&O | 19-03-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
Nuformix Technologies Ltd.
Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Hoofd Techniek/Wetenschap/O&O | 31-05-2021 |
| NUFORMIX PLC | Oprichter | 31-05-2021 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
University of Leeds
University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuformix Technologies Ltd.
Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Nuformix Plc
Nuformix Plc BiotechnologyHealth Technology Develops commercial technologies in pharmaceutical and biotechnology sector | Health Technology |
Conduit Pharmaceuticals, Inc.
Conduit Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage specialty biopharmaceutical company | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau